Literature DB >> 21799181

Knowing your ABCCs: novel functions of ABCC transporters.

Garrett M Brodeur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21799181      PMCID： PMC3156804          DOI： 10.1093/jnci/djr277

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  26 in total

1.  Mechanisms of multidrug resistance in cancer.

Authors:  Jean-Pierre Gillet; Michael M Gottesman
Journal:  Methods Mol Biol       Date:  2010

2.  Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.

Authors:  A T Look; F A Hayes; R Nitschke; N B McWilliams; A A Green
Journal:  N Engl J Med       Date:  1984-07-26       Impact factor: 91.245

3.  Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.

Authors:  J M Maris; M J Weiss; C Guo; R B Gerbing; D O Stram; P S White; M D Hogarty; E P Sulman; P M Thompson; J N Lukens; K K Matthay; R C Seeger; G M Brodeur
Journal:  J Clin Oncol       Date:  2000-05       Impact factor: 44.544

Review 4.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

5.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Authors:  R C Seeger; G M Brodeur; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

6.  Significance of chromosome 1p loss of heterozygosity in neuroblastoma.

Authors:  J M Maris; P S White; C P Beltinger; E P Sulman; R P Castleberry; J J Shuster; A T Look; G M Brodeur
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

7.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

Authors:  G M Brodeur; R C Seeger; M Schwab; H E Varmus; J M Bishop
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Coordinate morphological and biochemical interconversion of human neuroblastoma cells.

Authors:  R A Ross; B A Spengler; J L Biedler
Journal:  J Natl Cancer Inst       Date:  1983-10       Impact factor: 13.506

9.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

10.  ABCC multidrug transporters in childhood neuroblastoma: clinical and biological effects independent of cytotoxic drug efflux.

Authors:  Michelle J Henderson; Michelle Haber; Antonio Porro; Marcia A Munoz; Nunzio Iraci; Chengyuan Xue; Jayne Murray; Claudia L Flemming; Janice Smith; Jamie I Fletcher; Samuele Gherardi; Chin-Kiat Kwek; Amanda J Russell; Emanuele Valli; Wendy B London; Allen B Buxton; Lesley J Ashton; Alan C Sartorelli; Susan L Cohn; Manfred Schwab; Glenn M Marshall; Giovanni Perini; Murray D Norris
Journal:  J Natl Cancer Inst       Date:  2011-07-28       Impact factor: 13.506
View more
  3 in total

1.  Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs.

Authors:  Nadine Löschmann; Martin Michaelis; Florian Rothweiler; Richard Zehner; Jaroslav Cinatl; Yvonne Voges; Mohsen Sharifi; Kristoffer Riecken; Jochen Meyer; Andreas von Deimling; Iduna Fichtner; Taravat Ghafourian; Frank Westermann; Jindrich Cinatl
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

2.  Adenosine triphosphate-binding cassette subfamily C members in liver hepatocellular carcinoma: Bioinformatics-driven prognostic value.

Authors:  Xiangtong Meng; Shen Dong; Liu Yangyang; Song Wang; Xiaohao Xu; Tiejun Liu; Xiong Zhuang
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

3.  ABCB1 as predominant resistance mechanism in cells with acquired SNS-032 resistance.

Authors:  Nadine Löschmann; Martin Michaelis; Florian Rothweiler; Yvonne Voges; Barbora Balónová; Barry A Blight; Jindrich Cinatl
Journal:  Oncotarget       Date:  2016-09-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.